CN115452787A - Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles - Google Patents
Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles Download PDFInfo
- Publication number
- CN115452787A CN115452787A CN202211154362.7A CN202211154362A CN115452787A CN 115452787 A CN115452787 A CN 115452787A CN 202211154362 A CN202211154362 A CN 202211154362A CN 115452787 A CN115452787 A CN 115452787A
- Authority
- CN
- China
- Prior art keywords
- dna
- pdnps
- agncs
- milk
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 title claims abstract description 91
- 229960005322 streptomycin Drugs 0.000 title claims abstract description 43
- 239000008267 milk Substances 0.000 title claims abstract description 23
- 235000013336 milk Nutrition 0.000 title claims abstract description 23
- 210000004080 milk Anatomy 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 12
- BBKFSSMUWOMYPI-UHFFFAOYSA-N gold palladium Chemical compound [Pd].[Au] BBKFSSMUWOMYPI-UHFFFAOYSA-N 0.000 title claims abstract description 6
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 6
- 239000004332 silver Substances 0.000 title claims abstract description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims description 4
- 108091023037 Aptamer Proteins 0.000 claims abstract description 25
- 230000000171 quenching effect Effects 0.000 claims abstract description 12
- 238000010791 quenching Methods 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000011258 core-shell material Substances 0.000 claims abstract description 3
- 238000000151 deposition Methods 0.000 claims abstract description 3
- 238000000295 emission spectrum Methods 0.000 claims abstract description 3
- 230000035040 seed growth Effects 0.000 claims abstract description 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims abstract 4
- 230000001105 regulatory effect Effects 0.000 claims abstract 2
- 230000008859 change Effects 0.000 claims description 6
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract description 18
- 238000001514 detection method Methods 0.000 abstract description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 10
- 239000010931 gold Substances 0.000 abstract description 9
- 229910052737 gold Inorganic materials 0.000 abstract description 9
- 229910052763 palladium Inorganic materials 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- 239000011259 mixed solution Substances 0.000 description 10
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000002189 fluorescence spectrum Methods 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002082 metal nanoparticle Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012798 spherical particle Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940126574 aminoglycoside antibiotic Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000004850 capillary HPLC Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- ZFGJFDFUALJZFF-UHFFFAOYSA-K gold(3+);trichloride;trihydrate Chemical compound O.O.O.Cl[Au](Cl)Cl ZFGJFDFUALJZFF-UHFFFAOYSA-K 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- ONUMZHGUFYIKPM-MXNFEBESSA-N telavancin Chemical compound O1[C@@H](C)[C@@H](O)[C@](NCCNCCCCCCCCCC)(C)C[C@@H]1O[C@H]1[C@H](OC=2C3=CC=4[C@H](C(N[C@H]5C(=O)N[C@H](C(N[C@@H](C6=CC(O)=C(CNCP(O)(O)=O)C(O)=C6C=6C(O)=CC=C5C=6)C(O)=O)=O)[C@H](O)C5=CC=C(C(=C5)Cl)O3)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C3=CC=C(C(=C3)Cl)OC=2C=4)O[C@H](CO)[C@@H](O)[C@@H]1O ONUMZHGUFYIKPM-MXNFEBESSA-N 0.000 description 1
- 229960005240 telavancin Drugs 0.000 description 1
- 108010089019 telavancin Proteins 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Manufacturing & Machinery (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention provides a preparation method of a fluorescence aptamer sensor for detecting Streptomycin (STR) residues in milk, belonging to the field of food safety detection. The invention comprises a method for synthesizing a hairpin type DNA-silver nano cluster (DNA-AgNCs) regulated and controlled by guanine (G) base, synthesizing core-shell gold-palladium nano particles (Au @ PdNPs) and constructing a fluorescent sensor. According to the invention, different numbers of G bases are added into the hairpin loop, so that the red shift of the emission spectrum and the increase of the fluorescence intensity of DNA-AgNCs are realized. The Au @ PdNPs is prepared by a seed growth method and a deposition method, and the Au @ PdNPs composite material not only solves the problem that the quenching capacity of the palladium nanoparticles (PdNPs) is weak in the long wavelength range, but also effectively expands the fluorescence quenching range of the gold nanoparticles (AuNPs). The inventive sensor responded well to STRs in the range of 50-1250 nM with a limit of detection (LOD) of 18.7 nM. In addition, the invention has been successfully applied to STR detection in milk, and shows that the invention has good application prospect in STR detection in the field of animal-derived foods.
Description
Technical Field
The invention provides a preparation method of an aptamer sensor for detecting streptomycin residue in milk, and belongs to the technical field of food safety detection.
Background
Streptomycin (STR) is a common aminoglycoside antibiotic, is used for treating mastitis and other diseases caused by bacterial infection of cows, and can cause STR residues in dairy products such as milk if unreasonably used, thereby not only affecting the quality of the dairy products, but also causing serious harm to human bodies, including allergy, damage to intestinal flora and toxicity to kidneys.
Therefore, it is crucial to develop sensitive and specific technologies for detecting STR in foods of animal origin, such as milk, and at present, sensitive detection methods such as capillary electrophoresis, high performance liquid chromatography and enzyme-linked immunosorbent assay have been developed for detecting STR in milk residues, but their application is limited due to the disadvantages of long turnaround time, complicated steps, expensive equipment and high technical requirements.
Disclosure of Invention
The invention aims to establish a rapid, simple and efficient detection technology for detecting STR in milk.
The technical scheme is as follows: aptamers are high-affinity and specific RNA or ssDNA sequences screened by a number-enriched ligand systematic evolution technology (SELEX), and in recent years, due to the advantages of rapidness, sensitivity and easiness in operation, fluorescent sensors based on aptamers are widely applied.
The preparation method of the fluorescent aptamer sensor for detecting STR residues in milk (figure 1) is characterized by comprising the following steps: the method is characterized in that a G base group is added into a hairpin type DNA-silver nanocluster (DNA-AgNCs) ring to adjust the fluorescence spectrum of the DNA-AgNCs, a template chain of the DNA-AgNCs contains an STR aptamer (STP) sequence, the aptamer of the DNA-AgNCs is adsorbed on the surface of gold palladium nanoparticles (Au @ PdNPs) through coordination under the condition of no STR, therefore, energy is transferred from the fluorescence donor DNA-AgNCs to the Au @ PdNPs to cause fluorescence quenching, when the STR is added, the conformation of the aptamer is changed due to specific combination of the STR and the aptamer, the interaction between the aptamer and the Au @ PdNPs is weakened, the fluorescence signal is recovered, and the STR in the milk can be successfully detected based on the change of the fluorescence signal.
The preparation method of the fluorescent aptamer sensor for detecting STR residues in milk is characterized by comprising the following steps: in addition, the Au @ PdNPs composite material with excellent quenching property is synthesized, so that the problem of weak quenching capability of palladium nanoparticles (PdNPs) in a long wavelength range is solved, and the fluorescence quenching range of gold nanoparticles (AuNPs) is effectively expanded.
The preparation principle is as follows: on the basis of Fluorescence Resonance Energy Transfer (FRET), a fluorescence sensor utilizing DNA-AgNCs and core-shell gold-palladium nanoparticles (Au @ PdNPs) is designed to detect Streptomycin (STR) in milk, and an aptamer of the DNA-AgNCs is adsorbed on the surface of the Au @ PdNPs through coordination. DNA-AgNCs and Au @ PdNPs generate FRET, energy is transferred from fluorescence donor DNA-AgNCs to Au @ PdNPs, fluorescence quenching is caused, when STR is added, the specific binding of the STR and the aptamer causes the conformation of the aptamer to change, the FRET between the aptamer and the Au @ PdNPs is destroyed, and the recovery of fluorescence signals is caused.
In order to achieve the purpose, the following technical scheme is adopted for realizing the purpose: silver nanoclusters were prepared by first preparing all DNA template solutions (100. Mu.M) with TE buffer and holding in a water bath (95 ℃) for 10 minutes, then cooling the solution to room temperature in an ice-water bath, followed by 500. Mu.L of 100. Mu.M DNA solution and 300. Mu.L of 1 mM silver nitrate (AgNO) 3 ) The solutions were added to 3.9 ml of TE buffer, mixed thoroughly and shaken, all the mixed solutions were incubated in ice bath and in the dark for 30 minutes, and 300. Mu.L of 1 mM freshly prepared and ice-cold sodium borohydride (NaBH) was added to the mixed solutions, respectively 4 ) Solution, after the reaction is finished, fully shaking the mixed solution for 1 minute, and finally obtaining the productStoring the obtained solution at 4 deg.C in dark place, preparing Au @ PdNPs, and mixing 100 ml of 0.01% (w/v) gold chloride trihydrate (HAuCl) 4 ·3H 2 O) solution was heated to boiling, after which 2.7 mL of 1% (w/v) trisodium citrate (Na) were added rapidly 3 C 6 H 5 O 7 ) The solution was continuously heated and boiled until the color of the gold seed solution did not change, and then the gold seed solution was cooled to room temperature under constant stirring, followed by mixing 2.0 mL of the gold seed solution and 4 mL of 1% (w/v) HAuCl under vigorous stirring 4 ·3H 2 The O solution was added to 200 mL of ultrapure water, and after stirring well, 800. Mu.L of 1% (w/v) Na was added 3 C 6 H 5 O 7 Solution and 400. Mu.L of 30 mM Hydroquinone (C) 6 H 6 O 2 ) The solution is quickly added into the mixed solution for reduction. The above reducing agent was repeatedly added to the mixed solution 7 times at intervals of 10 minutes, and after the addition was completed, the mixed solution was further stirred for 1 hour, and finally, 1 mM H was synthesized by the following method 2 PdCl 4 Solution, 10.64 mg of palladium chloride (PdCl) 2 ) Is dissolved in 6 mL of 0.02M HCl solution and 54 mL of ultrapure water are added to the mixture in a water bath at 70 ℃ until PdCl 2 Complete dissolution to give 1 mM H 2 PdCl 4 Solutions of Au @ PdNPs obtained by deposition of Palladium, 30 mL of 75 nm AuNPs solution with 1 mL, 4 mL, 7 mL and 10 mL of H, respectively 2 PdCl 4 The solutions (1 mM) were mixed, the mixed solution was cooled in an ice bath, 1 mL, 4 mL, 7 mL and 10 mL ascorbic acid solution and 18 mL, 12 mL, 6 mL and 0 mL ultrapure water were respectively and slowly added to the mixed solution under vigorous stirring, then the mixed solution was further stirred for 30 minutes, after stirring, the resulting solution was centrifuged, washed with water-ethanol solution (1, 2, v/v) several times, and finally, au @ PdNPs were dissolved in C 6 H 5 Na 3 O 7 In solution (0.02%, w/v).
In order to achieve the purpose, the following technical scheme is adopted to realize the purpose: before detecting STR, the concentration of hairpin DNA-AgNCs is diluted to 1 μ M and the excitation wavelength is 586 nm in the whole experiment process, and the detection result of STR is obtained under the optimal experiment condition, 500 μ L of DNA-AgNCs and 500 μ L of Au @ PdNPs solution are mixed for 15 minutes, a series of STR solutions with different concentrations of 500 μ L are respectively added into the mixed solution of DNA-AgNCs and Au @ PdNPs, the reaction lasts for 60 minutes, and then the fluorescence intensity is measured.
The preparation process of the aptamer sensor comprises the following steps: STRs were added to milk at three concentration levels (300 nM, 600 nM and 900 nM) before pretreatment, and subsequently, the milk sample was pretreated by the following method, 20 mL of a milk-methanol (1, 4, v/v) mixture was kept at-20 ℃ for 20 minutes, then the mixture was centrifuged at 12500 rpm for 25 minutes, the supernatant was filtered through a membrane filter (0.22 μm), after filtration, the supernatant was concentrated and dried in a water bath at 60 ℃, the residue was dried with nitrogen and then reconstituted with ultrapure water, the reconstituted solution was filtered through a membrane filter (0.22 μm), and finally, the volume of the filtrate was set to 4 mL.
Drawings
FIG. 1 shows a process for constructing a fluorescence aptamer sensor.
FIG. 2 excitation and emission wavelengths of DNA-AgNCs synthesized from different template strands.
FIG. 3 fluorescence spectrum and fluorescence intensity of DNA-AgNCs.
FIG. 4 Electron microscopy characterization of nanomaterials.
Fig. 5 optimization of palladium shell thickness.
Figure 6 experimental conditions were optimized.
FIG. 7 fluorescent determination of STR.
FIG. 8 specific assay.
FIG. 9 STR testing in real samples of milk.
Detailed Description
Example 1: FIG. 3A shows fluorescence spectra of DNA-AgNCs of different template strand synthesis, excitation and emission wavelengths are listed in FIG. 2, and fluorescence intensity is shown in FIG. 3B, however, in DNA 2 、DNA 3 And DNA 4 、DNA 5 In (2), there is no regular red shift as the number of G bases increases, and when the number of G bases reaches 10 and 12, the red shift no longer occurs, when the number of bases is 0 to 6In time, the fluorescence intensity did not change much, however, when the number of G bases increased to 8, significant enhancement and change occurred due to DNA 4 -AgNCs、DNA 5 -AgNCs、DNA 6 AgNCs and DNA 7 The emission spectrum of AgNCs is close to the near infrared region, which means that it requires large metal nanoparticles, but larger metal nanoparticles may cause scattering, leading to a distortion of the fluorescence spectrum, DNA 3 Fluorescence intensity of AgNCs in DNA 1 -AgNCs、DNA 2 AgNCs and DNA 3 The strongest of the AgNCs, DNA 3 -position ratio DNA of maximum emission peak of AgNCs 2 The AgNCs are short, so the quencher nanoparticles required are smaller in diameter and less susceptible to scattering, and in summary, DNA was selected 3 AgNCs as fluorescent material used in this experiment.
Example 2: DNA Observation by TEM 3 Morphology of AgNCs, DNA synthesized as shown in FIG. 4A 3 AgNCs showed a uniform dispersion, almost circular, with an average size of 2.47 nm, and measured for DNA 3 Stability of AgNCs over 120 hours, results show, DNA 3 AgNCs are stable for 12-24 hours, so the experiment is on DNA 3 Measured DNA, performed within 12-24 hours after AgNCs synthesis 3 Absolute quantum yield of-AgNCs is 10.76%, TEM image of gold seeds is shown in FIG. 4B, from which it can be seen that the gold seeds are spherical particles with diameter of 19.9 nm, FIG. 4E shows large size gold nanoparticles synthesized by seed growth method with diameter of 75 nm, from FIGS. 4F-I, with different amount of H 2 PdCl 4 And ascorbic acid on the surface of AuNPs, it can be seen that the thickness of the palladium shell is about 4 nm, 7 nm, 11 nm and 16 nm, respectively, FIG. 4J-M shows EDX of Au @ PdNPs with diameter of 75+16 nm, it can be seen that palladium is dispersed in the outer layer of the gold core, the weight ratio of gold/palladium is 33.36/66.64, FIG. 4C, D shows SEM of Au @ PdNPs with diameter of 75+16 nm, according to the image, au @ PdNPs are almost spherical particles with diameter of 107.11 nm, the above analysis shows that Au @ PdNPs and DNA are almost spherical particles 3 The synthesis effect of the AgNCs is good.
Example 3: the optimization of the thickness of the palladium shell (FIG. 5), the energy transfer efficiencies (E) of 75+4 nm, 75+7 nm, 75+11 nm and 75+16 nm Au @ PdNPs are respectively 26.7%, 46.6%, 56.7% and 62.8%, it can be found that the energy transfer efficiency is gradually increased along with the increase of the thickness of the palladium shell, the 75+16 nm Au @ PdNPs has very high energy transfer efficiency which is enough to meet the experimental requirements, and meanwhile, the interference of metal nanoparticle scattering is increased by further increasing the particle size, so the 75+16 nm Au @ PdNPs with the highest quenching efficiency is selected as the quenching agent of the experiment.
Example 4: optimization of the conditions in the assay (FIG. 6), (A) optimization of the pH in the DNA-AgNCs synthesis (6.5-9.0), pH optimum 7.5, (B) addition of 0-24.8 pm concentrations of Au @ PdNPs to 1. Mu.M DNA 3 In AgNCs, the optimal concentration of Au @ PdNPs is 17.2 pM, (C) the incubation time for fluorescence quenching (0-30 min), the optimal quenching time is 15min, and (D) the incubation time for fluorescence recovery (0-90 min), and the optimal recovery time is 60min.
Example 5: the performance of the sensor for determining the analyte is evaluated by measuring STRs with different concentrations, as shown in FIG. 7, the fluorescence intensity gradually increases with the increase of the STR concentration within the range of 50 to 2800 nM, the fluorescence intensity and the STR concentration have a positive linear relation within the range of 50 to 1250 nM, and the equation of a linear calibration curve is as follows: i =0.43314C STR +102.94683, correlation coefficient (R) 2 ) 0.99258, with a limit of detection (LOD) of the STR fluorometry of 18.7 nM according to 3 σ/k, where σ is the standard deviation of the measurement of the calibration standard blank (n = 10) and k is the slope of the calibration curve.
Example 6: to evaluate the specificity of the sensor, the specificity of the DNA-AgNCs-based fluorescence aptamer was determined by comparison with other antibiotics such as Telavancin (TER), chloramphenicol (CHL), tetracycline (TET), erythromycin (ERY), chlortetracycline hydrochloride (CHH) and Penicillin (PEN), at a concentration 10 times that of STR, as shown in FIG. 8, I and I 0 Indicating the fluorescence intensity in the presence and absence of different types of antibiotics, respectively, and that STR responds to fluorescence aptamers more strongly than other antibiotics, these results indicate that fluorescence adaptationThe instrument has strong specificity for detecting STR, and shows that the developed fluorescence adapter can be used for detecting STR.
Example 7: to evaluate the feasibility of this invention to detect STR in milk samples, we added three different concentrations of streptomycin to actual milk, and the recovery is shown in fig. 9, and it can be seen that the peak recovery of kanamycin detection is between 97.45% and 105.34%, and the Relative Standard Deviation (RSD) is between 1.05% and 3.04%, and these excellent properties indicate the feasibility of our proposed streptomycin detection method in this application.
Claims (4)
1. A preparation method of a fluorescence aptamer sensor for detecting streptomycin in milk is characterized by comprising the following steps: a fluorescence aptamer sensor based on guanine (G) base-regulated hairpin-type DNA silver nanoclusters (DNA-AgNCs) and core-shell gold-palladium nanoparticles (Au @ PdNPs) is constructed and used for detecting Streptomycin (STR).
2. The method for preparing an aptamer sensor for detecting streptomycin in milk according to claim 1, wherein the aptamer sensor comprises: different numbers of G bases were added to the hairpin loop to achieve a red shift in the emission spectrum and an increase in the fluorescence intensity of the DNA-AgNCs.
3. The method of claim 1, wherein the aptamer sensor for detecting streptomycin in milk comprises: the excellent quenching material Au @ PdNPs is prepared by a seed growth method and a deposition method, the Au @ PdNPs and the DNA-AgNCs are utilized to carry out fluorescence resonance energy transfer, and the streptomycin is detected by the change of fluorescence signals of the Au @ PdNPs and the DNA-AgNCs under the corresponding excitation wavelength.
4. The method of claim 1, wherein the aptamer sensor for detecting streptomycin in milk comprises: the sensor has better sensing performance, and can detect STR residues in an actual milk sample.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211154362.7A CN115452787A (en) | 2022-09-22 | 2022-09-22 | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211154362.7A CN115452787A (en) | 2022-09-22 | 2022-09-22 | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115452787A true CN115452787A (en) | 2022-12-09 |
Family
ID=84306013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211154362.7A Pending CN115452787A (en) | 2022-09-22 | 2022-09-22 | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115452787A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115894624A (en) * | 2022-12-29 | 2023-04-04 | 吉林大学 | Gold nanocluster using polypeptide as ligand and detection method of chlortetracycline hydrochloride |
CN116200538A (en) * | 2022-12-12 | 2023-06-02 | 盐城工学院 | Application of nano kite sensor in preparation of multi-target virus gene detection reagent |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140024137A1 (en) * | 2012-07-11 | 2014-01-23 | Nubad, LLC | Methods and compositions related to nucleic acid binding assays |
US20150240297A1 (en) * | 2012-07-31 | 2015-08-27 | Juan Carlos Jaime | Method for obtaining and detecting a marker of objects to be identified, related marker, authentication method and verification method |
US20170166890A1 (en) * | 2013-06-14 | 2017-06-15 | The University Of Notre Dame | Dnazyme-nanoparticle conjugates and methods of use thereof |
CN108315421A (en) * | 2018-04-04 | 2018-07-24 | 山东师范大学 | Method of the constant-temperature amplification with the combination of quantum dot fluorescence Resonance energy transfer for detecting a variety of MicroRNAs simultaneously |
CN108445031A (en) * | 2018-04-26 | 2018-08-24 | 山东理工大学 | A kind of preparation method of aptamer sensor that is while detecting kanamycins and Determination of Streptomycin Residues |
WO2021004379A1 (en) * | 2019-07-05 | 2021-01-14 | 南京金斯瑞生物科技有限公司 | Fluorescently labeled nucleic acid and synthesis method therefor |
CN112893864A (en) * | 2021-01-20 | 2021-06-04 | 江南大学 | Silver nanocluster prepared based on hairpin template and application of silver nanocluster in chloramphenicol detection |
WO2021145796A2 (en) * | 2020-01-14 | 2021-07-22 | Максим Петрович НИКИТИН | Method of determining analyte content in a sample with the aid of a nanoparticle-based agent and a recognition oligonucleotide |
WO2021175762A1 (en) * | 2020-03-03 | 2021-09-10 | Universiteit Gent | Hydrolysis-based probe and method for str genotyping |
CN114136944A (en) * | 2021-12-10 | 2022-03-04 | 山东理工大学 | Preparation method of fluorescence aptamer sensor for detecting kanamycin residue in milk |
CN114518359A (en) * | 2022-03-08 | 2022-05-20 | 山东理工大学 | Preparation method of G-quadruplet-based dual-mode kanamycin aptamer sensor |
CN114624223A (en) * | 2022-03-15 | 2022-06-14 | 山东农业大学 | Method for detecting streptomycin based on surface enhanced Raman spectroscopy sensor embedded with specific nuclease DNA hydrogel |
-
2022
- 2022-09-22 CN CN202211154362.7A patent/CN115452787A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140024137A1 (en) * | 2012-07-11 | 2014-01-23 | Nubad, LLC | Methods and compositions related to nucleic acid binding assays |
US20150240297A1 (en) * | 2012-07-31 | 2015-08-27 | Juan Carlos Jaime | Method for obtaining and detecting a marker of objects to be identified, related marker, authentication method and verification method |
US20170166890A1 (en) * | 2013-06-14 | 2017-06-15 | The University Of Notre Dame | Dnazyme-nanoparticle conjugates and methods of use thereof |
CN108315421A (en) * | 2018-04-04 | 2018-07-24 | 山东师范大学 | Method of the constant-temperature amplification with the combination of quantum dot fluorescence Resonance energy transfer for detecting a variety of MicroRNAs simultaneously |
CN108445031A (en) * | 2018-04-26 | 2018-08-24 | 山东理工大学 | A kind of preparation method of aptamer sensor that is while detecting kanamycins and Determination of Streptomycin Residues |
WO2021004379A1 (en) * | 2019-07-05 | 2021-01-14 | 南京金斯瑞生物科技有限公司 | Fluorescently labeled nucleic acid and synthesis method therefor |
WO2021145796A2 (en) * | 2020-01-14 | 2021-07-22 | Максим Петрович НИКИТИН | Method of determining analyte content in a sample with the aid of a nanoparticle-based agent and a recognition oligonucleotide |
WO2021175762A1 (en) * | 2020-03-03 | 2021-09-10 | Universiteit Gent | Hydrolysis-based probe and method for str genotyping |
CN112893864A (en) * | 2021-01-20 | 2021-06-04 | 江南大学 | Silver nanocluster prepared based on hairpin template and application of silver nanocluster in chloramphenicol detection |
CN114136944A (en) * | 2021-12-10 | 2022-03-04 | 山东理工大学 | Preparation method of fluorescence aptamer sensor for detecting kanamycin residue in milk |
CN114518359A (en) * | 2022-03-08 | 2022-05-20 | 山东理工大学 | Preparation method of G-quadruplet-based dual-mode kanamycin aptamer sensor |
CN114624223A (en) * | 2022-03-15 | 2022-06-14 | 山东农业大学 | Method for detecting streptomycin based on surface enhanced Raman spectroscopy sensor embedded with specific nuclease DNA hydrogel |
Non-Patent Citations (2)
Title |
---|
WANG, XIAOYANG ETAL.: "A novel fluorescence sensor for streptomycin detection based on hairpin DNA-AgNCs and core-shell gold-palladium nanoparticles", 《SENSORS AND ACTUATORS B-CHEMICAL》, vol. 373, 15 December 2022 (2022-12-15) * |
阿说阿沙 等: "荧光免疫分析法在牛奶抗生素残留检测中的研究进展", 《中国兽医杂志》, vol. 55, no. 09, 30 September 2019 (2019-09-30) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116200538A (en) * | 2022-12-12 | 2023-06-02 | 盐城工学院 | Application of nano kite sensor in preparation of multi-target virus gene detection reagent |
CN115894624A (en) * | 2022-12-29 | 2023-04-04 | 吉林大学 | Gold nanocluster using polypeptide as ligand and detection method of chlortetracycline hydrochloride |
CN115894624B (en) * | 2022-12-29 | 2023-12-08 | 吉林大学 | Gold nanocluster with polypeptide as ligand and detection method of aureomycin hydrochloride |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115452787A (en) | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles | |
Liu et al. | Construction of biomass carbon dots based fluorescence sensors and their applications in chemical and biological analysis | |
Li et al. | Designing an aptamer based magnetic and upconversion nanoparticles conjugated fluorescence sensor for screening Escherichia coli in food | |
CN113155807B (en) | MicroRNA ultrasensitive detection method based on surface enhanced Raman spectroscopy technology | |
Zhou et al. | Gold nanobones enhanced ultrasensitive surface-enhanced Raman scattering aptasensor for detecting Escherichia coli O157: H7 | |
Lu et al. | Target-driven switch-on fluorescence aptasensor for trace aflatoxin B1 determination based on highly fluorescent ternary CdZnTe quantum dots | |
Kong et al. | Carbon dots for fluorescent detection of α-glucosidase activity using enzyme activated inner filter effect and its application to anti-diabetic drug discovery | |
Wang et al. | Magnetic plasmonic particles for SERS-based bacteria sensing: A review | |
Jayan et al. | Mesoporous silica coated core-shell nanoparticles substrate for size-selective SERS detection of chloramphenicol | |
Wei et al. | A novel gold nanostars-based fluorescent aptasensor for aflatoxin B1 detection | |
Ren et al. | A novel fluorescence resonance energy transfer (FRET)-based paper sensor with smartphone for quantitative detection of Vibrio parahaemolyticus | |
CN108535236B (en) | Method for ultrasensitively detecting miRNA based on dual-amplification SERS signal system | |
US8263668B2 (en) | Tunable fluorescent gold nanocluster and method for forming the same | |
CN110455756B (en) | Method for simultaneously detecting divalent lead ions and divalent copper ions | |
CN113005180A (en) | Magnetic SERS biosensor and preparation method and application thereof | |
CN115825037B (en) | Preparation method and application of hydrogel-loaded gold nanoparticle SERS substrate | |
CN109387500B (en) | Method for detecting escherichia coli based on magnetic graphene oxide composite star @ gold-silver alloy nanoparticles | |
CN109303923B (en) | Method for preparing nano-cluster gel containing hydroxyapatite-like component | |
KR20210019767A (en) | Magnetic-Optical Composite Nanoparticles | |
Li et al. | Recent advances in rare earth ion‐doped upconversion nanomaterials: From design to their applications in food safety analysis | |
WO2010114297A2 (en) | Microsphere having hot spots and method for identifying chemicals through surface enhanced raman scattering using the same | |
Wang et al. | A novel fluorescence sensor for streptomycin detection based on hairpin DNA-AgNCs and core-shell gold-palladium nanoparticles | |
Gao et al. | A sensitive colorimetric aptasensor for chloramphenicol detection in fish and pork based on the amplification of a nano-peroxidase-polymer | |
Kumar et al. | Fast tyrosinase detection in early stage melanoma with nanomolar sensitivity using a naphthalimide-based fluorescent read-out probe | |
CN112710649B (en) | Method for detecting kanamycin sulfate by using dual-signal-enhanced surface-enhanced Raman spectroscopy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |